St. Johns, FL, United States of America

Michael W Lovell


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael W. Lovell - Innovator in Cancer Treatment

Introduction

Michael W. Lovell, based in St. Johns, FL, has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cancer treatments. His innovative approach has led to the invention of a specific formulation that addresses critical health challenges, showcasing his role as an influential inventor.

Latest Patents

Michael W. Lovell holds one patent, which is for a STAT3 inhibitor formulation. This important patent discloses a salt derived from the STAT3 inhibitor, known as 2-hydroxy-4-[[2-[[(4-methylphenyl)sulfonyl]oxy]acetyl]amino] benzoic acid and 2-amino-2-(hydroxymethyl)-1,3-propanediol. This salt is characterized by its solubility in water and its stability over extended periods. Additionally, the patent outlines pharmaceutical compositions that incorporate this salt and methods for using it to prevent and treat various forms of cancer, including breast cancer.

Career Highlights

Throughout his career, Michael W. Lovell has been associated with esteemed organizations. He worked with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, contributing his expertise to public health initiatives. Furthermore, he has been involved with GLG Pharma, LLC, where he could leverage his innovative ideas in a commercial context.

Collaborations

Collaboration has played a vital role in Michael W. Lovell's career. He has worked alongside notable colleagues such as Robert H. Shoemaker and Jonathan M. White. Their teamwork highlights the importance of collaborative research and development in advancing therapeutic solutions.

Conclusion

In summary, Michael W. Lovell stands out as a dedicated inventor whose work in developing a STAT3 inhibitor formulation has the potential to change the landscape of cancer treatment. His collaborations and professional associations underscore the collaborative spirit essential in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…